Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Reka Pataky"'
Publikováno v:
PharmacoEconomics. 40(10)
Precision medicine highlights the importance of exploring heterogeneity in the effectiveness and costs of interventions. Our objective was to identify and compare frameworks for valuing heterogeneity-informed decisions, and consider their strengths a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad18ea10dcc5db0908dd6fa040f45b6f
https://pubmed.ncbi.nlm.nih.gov/35895254
https://pubmed.ncbi.nlm.nih.gov/35895254
Publikováno v:
JCO precision oncology. 2
Purpose Precision oncology has the potential to improve patient health and reduce treatment costs. Yet the up-front cost of genomic testing with next-generation sequencing (NGS) technologies can be prohibitive. Our study is a structured review of eco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39181d8570d616eb4fe66a0c8df89b11
https://pubmed.ncbi.nlm.nih.gov/35135140
https://pubmed.ncbi.nlm.nih.gov/35135140
Autor:
Wei Fang Dai, Erind Dvorani, Winson Y. Cheung, Kelvin K. W. Chan, David A. Tran, Riaz Alvi, Jaclyn Beca, Scott Gavura, Stuart Peacock, Wanrudee Isaranuwatchai, Reka Pataky, Craig C. Earle
Publikováno v:
MDM Policy & Practice, Vol 6 (2021)
MDM Policy & Practice
MDM Policy & Practice
Background. Real-world evidence can be a valuable tool when clinical trial data are incomplete or uncertain. Bevacizumab was adopted as first-line therapy for metastatic colorectal cancer (mCRC) based on significant survival improvements in initial c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd56fb864de4dade2f8d0fccb11b7f4
https://doaj.org/article/bf453391baff492eb408bacb74c46018
https://doaj.org/article/bf453391baff492eb408bacb74c46018
Autor:
Karen E. Bremner, Jagadish Rangrej, Reka Pataky, Winson Y. Cheung, Claire de Oliveira, Stuart Peacock, Jeffrey S Hoch, Murray Krahn, Kelvin K. W. Chan
Publikováno v:
Healthcare policy = Politiques de sante, vol 12, iss 3
Healthcare Policy
Healthcare Policy
Author(s): De Oliveira, Claire; Pataky, Reka; Bremner, Karen E; Rangrej, Jagadish; Chan, Kelvin KW; Cheung, Winson Y; Hoch, Jeffrey S; Peacock, Stuart; Krahn, Murray D | Abstract: BackgroundCosting studies are useful to measure the economic burden of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b43e25b0a7ea263afaa579048b465d
https://doi.org/10.12927/hcpol.2017.25024
https://doi.org/10.12927/hcpol.2017.25024
Autor:
Konrad Fassbender, Rinku Sutradhar, Jonathan Sussman, Lisa Barbera, Fred Burge, Hsien Seow, Reka Pataky, Beverley Lawson, Kim McGrail
Publikováno v:
Journal of Palliative Medicine. 19:263-270
Most cancer patients want to die at home, but scaleable models to achieve this are not well researched. Our objective was to investigate the temporal association of homecare nursing, especially by generalist nurses, with reduced end-of-life hospitali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0ec99b347f02e3042ad3baa31d347e
https://doi.org/10.1089/jpm.2015.0229
https://doi.org/10.1089/jpm.2015.0229
Autor:
Konrad Fassbender, Reka Pataky, Melissa C. Brouwers, Rinku Sutradhar, Erin O'Leary, Fred Burge, Lisa Barbera, Beverley Lawson, Kim McGrail, Hsien Seow
Publikováno v:
Journal of Pain and Symptom Management. 51:204-212
Context Despite being commonplace in health care systems, little research has described home care nursing's effectiveness to reduce acute care use at the end of life. Objectives To examine the temporal association between home care nursing rate on em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c062a5be41ba5e710c7eae224ca43de2
https://doi.org/10.1016/j.jpainsymman.2015.10.008
https://doi.org/10.1016/j.jpainsymman.2015.10.008
Autor:
Andrea Coronado, David A. Tran, Reka Pataky, Darryl Boehm, Stuart Peacock, Dean A. Regier, Riaz Alvi
Background Expenditure on systemic therapy for cancer has been increasing quickly owing to population growth, increased use, both in the number of users and in prescription volume, and rising drug prices. Our objective was to describe trends in expen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd610fea831b666ae5bf2de7cd56ead
https://europepmc.org/articles/PMC6182106/
https://europepmc.org/articles/PMC6182106/
Autor:
Kimberlyn McGrail, Lisa Barbera, Reka Pataky, Rinku Sutradhar, Konrad Fassbender, Fred Burge, Hsien Seow, Beverley Lawson, Alex Potapov, Y. Liu, A. Chu
Publikováno v:
Current Oncology
Volume 22
Issue 5
Pages 2636-355
Volume 22
Issue 5
Pages 2636-355
The quality of data comparing care at the end of life (eol) in cancer patients across Canada is poor. This project used identical cohorts and definitions to evaluate quality indicators for eol care in British Columbia, Alberta, Ontario, and Nova Scot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c51a7bbf6a1fa1092a7b45f43273906
https://doi.org/10.3747/co.22.2636
https://doi.org/10.3747/co.22.2636
Autor:
Reka Pataky, Gail P. Jarvik, Stuart Peacock, Dean A. Regier, Jeffrey S Hoch, David L. Veenstra, Kimberly van der Hoek
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol 187, iss 6
Background: An important challenge with the application of next-generation sequencing technology is the possibility of uncovering incidental genomic findings. A paucity of evidence on personal utility for incidental findings has hindered clinical gui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eea4bfcad3bdcc68149f723fe5d16e5
https://doi.org/10.1503/cmaj.140697
https://doi.org/10.1503/cmaj.140697
Autor:
Zhaolin Xu, Diana N. Ionescu, David M. Hwang, Frances A. Shepherd, John R. Mayo, Annette McWilliams, Stuart Peacock, John Yee, Emily McPherson, Sonya Cressman, Reka Pataky, Don D. Sin, S. Atkar-Khattra, Ming-Sound Tsao, Natasha B. Leighl, Christian Couture, Paul Burrowes, William K. Evans, Stephen Lam, Michael R. Johnston, Stefan J. Urbanski, Paul MacEachern, John R. Goffin, Garth Nicholas, Kazuhiro Yasufuku, John C. English, Rick Bhatia, Kayvan Amjadi, Daria Manos, Geoffrey Liu, Wan C. Tan, Harmanjatinder S. Sekhon, Heidi Schmidt, Simon Martel, Glenwood D. Goss, Alain Tremblay, Kam Soghrati, Martin C. Tammemägi, Serge Puksa
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 12(8)
Introduction Lung cancer risk prediction models have the potential to make programs more affordable; however, the economic evidence is limited. Methods Participants in the National Lung Cancer Screening Trial (NLST) were retrospectively identified wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea23bc3d96985faa523af2b8b86d531
https://pubmed.ncbi.nlm.nih.gov/28748812
https://pubmed.ncbi.nlm.nih.gov/28748812